Stock listing
ASX:BMT Beamtree Holdings Ltd Share Price
Follow Beamtree Holdings Ltd into a list and get an email when it puts out news.
Share price · ASX:BMT
$0.065 AUD -0.003 (-4.4%)
Close on Nov 20, 2026
- Day range
- $0.065 – $0.067 AUDNov 20, 2026
- Volume
- 22,555 sharesNov 20, 2026
- Market cap
- $19.20M AUDAt the close on Nov 20, 2026 · price × 295.3M shares outstanding
- 52-week range
- $0.063 – $0.225 AUDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $10,858 AUDMedian day 70,363 shares · 8 days with no trades · last 3 months, Aug 20, 2026 – Nov 20, 2026

Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · ASX:BMT · AUD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.065 | -0.003 | -4.4% | $0.067 | $0.067 | $0.065 | 22,555 | |
| $0.068 | +0.001 | +1.5% | $0.068 | $0.068 | $0.068 | 87,832 | |
| $0.067 | -0.001 | -1.5% | $0.068 | $0.068 | $0.067 | 126,734 | |
| $0.068 | 0.000 | 0.0% | $0.068 | $0.068 | $0.068 | 30,000 | |
| $0.068 | -0.004 | -5.6% | $0.067 | $0.073 | $0.065 | 63,946 | |
| $0.072 | 0.000 | 0.0% | $0.072 | $0.072 | $0.072 | 0 | |
| $0.072 | 0.000 | 0.0% | $0.071 | $0.073 | $0.071 | 62,158 | |
| $0.072 | +0.002 | +2.9% | $0.070 | $0.072 | $0.070 | 215,086 | |
| $0.070 | 0.000 | 0.0% | $0.071 | $0.071 | $0.070 | 715,466 | |
| $0.070 | +0.004 | +6.1% | $0.064 | $0.071 | $0.064 | 232,139 | |
| $0.066 | +0.002 | +3.1% | $0.065 | $0.066 | $0.065 | 326,523 | |
| $0.064 | -0.002 | -3.0% | $0.065 | $0.065 | $0.064 | 259,353 | |
| $0.066 | -0.005 | -7.0% | $0.065 | $0.066 | $0.063 | 198,226 | |
| $0.071 | -0.001 | -1.4% | $0.071 | $0.071 | $0.071 | 149,961 | |
| $0.072 | +0.001 | +1.4% | $0.071 | $0.076 | $0.071 | 616,503 | |
| $0.071 | -0.006 | -7.8% | $0.078 | $0.078 | $0.070 | 123,592 | |
| $0.077 | 0.000 | 0.0% | $0.077 | $0.077 | $0.077 | 104,638 | |
| $0.077 | +0.002 | +2.7% | $0.077 | $0.077 | $0.077 | 72,726 | |
| $0.075 | 0.000 | 0.0% | $0.075 | $0.075 | $0.075 | 11,638 | |
| $0.075 | -0.014 | -15.7% | $0.089 | $0.089 | $0.075 | 253,246 | |
| $0.089 | -0.001 | -1.1% | $0.089 | $0.089 | $0.089 | 5,000 | |
| $0.090 | 0.000 | 0.0% | $0.090 | $0.090 | $0.090 | 5,000 | |
| $0.090 | 0.000 | 0.0% | $0.090 | $0.090 | $0.090 | 0 | |
| $0.090 | 0.000 | 0.0% | $0.090 | $0.090 | $0.090 | 0 | |
| $0.090 | -0.003 | -3.2% | $0.093 | $0.093 | $0.090 | 76,100 | |
| $0.093 | +0.003 | +3.3% | $0.093 | $0.093 | $0.093 | 1,075 | |
| $0.090 | -0.001 | -1.1% | $0.090 | $0.090 | $0.090 | 68,000 | |
| $0.091 | 0.000 | 0.0% | $0.091 | $0.091 | $0.091 | 8,000 | |
| $0.091 | +0.008 | +9.6% | $0.090 | $0.091 | $0.090 | 109,547 | |
| $0.083 | 0.000 | 0.0% | $0.083 | $0.083 | $0.082 | 21,310 | |
| $0.083 | -0.007 | -7.8% | $0.088 | $0.090 | $0.083 | 125,109 | |
| $0.090 | 0.000 | 0.0% | $0.090 | $0.090 | $0.090 | 0 | |
| $0.090 | -0.010 | -10.0% | $0.094 | $0.094 | $0.090 | 24,976 | |
| $0.100 | 0.000 | 0.0% | $0.100 | $0.100 | $0.100 | 0 | |
| $0.100 | 0.000 | 0.0% | $0.100 | $0.100 | $0.100 | 5,000 | |
| $0.100 | 0.000 | 0.0% | $0.100 | $0.100 | $0.100 | 30,000 | |
| $0.100 | +0.008 | +8.7% | $0.092 | $0.100 | $0.092 | 27,445 | |
| $0.092 | -0.005 | -5.2% | $0.095 | $0.095 | $0.092 | 56,798 | |
| $0.097 | -0.003 | -3.0% | $0.097 | $0.097 | $0.097 | 100,000 | |
| $0.100 | 0.000 | 0.0% | $0.100 | $0.100 | $0.100 | 0 | |
| $0.100 | -0.005 | -4.8% | $0.100 | $0.100 | $0.095 | 167,554 | |
| $0.105 | -0.010 | -8.7% | $0.110 | $0.110 | $0.100 | 138,435 | |
| $0.115 | 0.000 | 0.0% | $0.115 | $0.115 | $0.115 | 0 | |
| $0.115 | 0.000 | 0.0% | $0.115 | $0.115 | $0.115 | 11,638 | |
| $0.115 | +0.010 | +9.5% | $0.115 | $0.115 | $0.115 | 1,026 | |
| $0.105 | 0.000 | 0.0% | $0.105 | $0.105 | $0.100 | 283,939 | |
| $0.105 | 0.000 | 0.0% | $0.105 | $0.105 | $0.100 | 127,917 | |
| $0.105 | 0.000 | 0.0% | $0.113 | $0.115 | $0.105 | 233,282 | |
| $0.105 | 0.000 | 0.0% | $0.105 | $0.105 | $0.105 | 12,324 | |
| $0.105 | 0.000 | 0.0% | $0.110 | $0.110 | $0.105 | 122,732 | |
| $0.105 | -0.005 | -4.5% | $0.110 | $0.120 | $0.105 | 146,777 | |
| $0.110 | 0.000 | 0.0% | $0.110 | $0.110 | $0.110 | 0 | |
| $0.110 | -0.005 | -4.3% | $0.115 | $0.115 | $0.110 | 318,999 | |
| $0.115 | -0.005 | -4.2% | $0.115 | $0.115 | $0.115 | 64,814 | |
| $0.120 | +0.010 | +9.1% | $0.110 | $0.120 | $0.110 | 225,217 | |
| $0.110 | -0.005 | -4.3% | $0.110 | $0.120 | $0.100 | 809,592 | |
| $0.115 | +0.010 | +9.5% | $0.100 | $0.115 | $0.100 | 146,929 | |
| $0.105 | -0.005 | -4.5% | $0.100 | $0.110 | $0.100 | 136,898 | |
| $0.110 | -0.010 | -8.3% | $0.120 | $0.120 | $0.110 | 220,314 | |
| $0.120 | -0.010 | -7.7% | $0.120 | $0.120 | $0.120 | 1,421 | |
| $0.130 | +0.005 | +4.0% | $0.125 | $0.130 | $0.120 | 40,478 | |
| $0.125 | 0.000 | 0.0% | $0.125 | $0.130 | $0.125 | 35,479 | |
| $0.125 | +0.005 | +4.2% | $0.110 | $0.135 | $0.110 | 132,631 | |
| $0.120 | +0.005 | +4.3% | $0.115 | $0.120 | $0.115 | 67,096 | |
| $0.115 | -0.005 | -4.2% | $0.120 | $0.120 | $0.105 | 29,869 | |
| $0.120 | +0.012 | +11.6% | $0.110 | $0.120 | $0.110 | 142,161 |
- Ticker
- ASX:BMT
- Asset type
- Stock
- Sector
- Health care
- Industry
- Health care services
- Exchange
- ASX
- Currency
- AUD
What changed lately
Latest news release · Oct 22, 2026
Annual Report to shareholders
Latest deck · Aug 28, 2026
FY2026 Earnings Presentation
Earnings · 19 slides
Latest news
Annual Report to shareholders
Oct 22, 2026
Closed $0.075 (-15.7%) on Oct 23, 2026
Notice of Annual General Meeting/Proxy Form
Oct 22, 2026
Closed $0.075 (-15.7%) on Oct 23, 2026
Notification of cessation of securities - BMT
Oct 20, 2026
Closed $0.09 (0.0%) on Oct 21, 2026
Change of Director's Interest Notice - M Hill
Sep 3, 2026
Closed $0.12 (+9.1%) on Sep 4, 2026
Change of Director's Interest Notice - M Bowles
Aug 31, 2026
Closed $0.105 (-4.5%) on Sep 1, 2026
Cleansing Notice
Aug 27, 2026
Closed $0.12 (-7.7%) on Aug 28, 2026
Application for quotation of securities - BMT
Aug 27, 2026
Closed $0.12 (-7.7%) on Aug 28, 2026
FY26 Annual Results Investor Presentation
Aug 27, 2026
Closed $0.12 (-7.7%) on Aug 28, 2026
Appendix 4G and Corporate Governance Statement
Aug 27, 2026
Closed $0.12 (-7.7%) on Aug 28, 2026
FY26 Full-Year Investor Update
Aug 27, 2026
Closed $0.12 (-7.7%) on Aug 28, 2026
Beamtree Holdings Ltd on 6ix
- Sector
- Health care
- Industry
- Health care services
- News releases
- 24 in the last 12 months · 107 in all · newest Oct 22, 2026 · oldest 2019
- Decks
- 23 decks · latest Aug 28, 2026
Valuation
EV/sales 0.7× against a median of 1.4×: 5th lowest of 11 Health care services companies shown. Statements: Year to Jun 30, 2026 · price Nov 20, 2026
- Enterprise value
- $20.72M AUD
- P/E
- Loss
- EV/sales
- 0.7×
- EV/EBITDA
- 149×
- Price/book
- 0.8×
- Gross margin
- −2.5%
- Operating margin
- −17.1%
- Net margin
- −62.6%
- Debt to equity
- 0.2×
- Beta
- No index for this market yet
Health care services: the 10 companies nearest in size, of 419 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Beamtree Holdings Ltd · ASX:BMT | US$12.71M | US$13.72M | n/a | 0.7× | 149× | 0.8× | −62.6% | 0.2× | n/a |
| Pacific Health Care Organization, Inc. · OTC:PFHO | US$14.08M | US$11.43M | 12.9× | 1.8× | n/a | 1.0× | 17.1% | 0.0× | -0.39 |
| PT Millennium Pharmacon International Tbk · IDX:SDPC | US$13.47M | US$63.80M | 5.9× | 0.3× | 7.4× | 0.7× | 1.0% | 2.9× | n/a |
| Genesis Fertility Center Public Company Limited · SET:GFC | US$12.70M | US$9.80M | 19.3× | 0.9× | 4.0× | 0.8× | 6.3% | 0.0× | n/a |
| Talius Group Limited · ASX:TAL | US$12.55M | US$9.78M | n/a | 1.9× | n/a | 3.1× | −19.1% | 0.1× | n/a |
| Mukdahan International Hospital Public Company Limited · SET:HANN | US$12.20M | US$9.07M | 66.8× | 0.7× | 6.3× | 1.4× | 1.4% | 0.1× | n/a |
| Alzai Health Corp. · TSXV:ALZI | US$11.86M | US$10.93M | n/a | 227× | n/a | 11.2× | n/a | 0.4× | n/a |
| Unipharma Co., Ltd. · TPEX:6621 | US$11.79M | US$8.53M | n/a | 3.2× | n/a | 2.0× | −45.8% | 0.0× | n/a |
| Eukedos SpA · MIL:EUK | US$11.73M | US$11.27M | n/a | 0.2× | 1.2× | 0.4× | −1.4% | 0.0× | n/a |
| ImExHS Ltd · ASX:IME | US$11.16M | US$10.15M | n/a | 0.5× | 10.1× | 1.0× | −10.0% | 0.0× | n/a |
| Intrasense SA · EURONEXT:ALINS | US$11.00M | US$10.61M | n/a | 3.3× | n/a | n/a | −364.8% | n/a | n/a |
| Median of the others | US$12.03M | US$10.38M | 16.1× | 1.4× | 6.3× | 1.0× | −1.4% | 0.0× | -0.39 |
Forecasts
Analysts' consensus from EODHD, read Nov 10, 2026. Not 6ix's view and not investment advice.
- Price target
- 0.25 AUD · Analysts' mean
- EPS, year to Jun 2027
- -0.004 · 1 analyst
- Revenue, year to Jun 2027
- 28.97M · 1 analyst
Team and board
Officers
| Officer | Role |
|---|---|
| Gareth Pye | Chief Executive Officer |
| Neil Thompson | Chief Financial Officer |
| Anna Winyard | General Manager, UK and Europe |
| Cheryl McCullagh | General Manager, ANZ Chief Clinical and Innovation Officer |
| David Crockett | Chief Growth Officer |
| Evan Simmons | Head of Diagnostics Products |
| Hani Obeid | General Manager, Saudi Arabia and Middle East |
| Julia Cooper | General Manager of Health Roundtable |
| Kateena Mills | Head of People & Culture |
| Larissa Mason | Head of Clinical Decision Support |
| Marek Stepniak | Head of International |
| Stephen Badham | Head of Coding Products |
| Stephen Morgan | Chief Technology Officer |
Board
| Director | Role |
|---|---|
| Andy Hardy | Non-Executive Director |
| Emma Gray | |
| Martin Bowles AO PSM | |
| Mike Hill | Non-Executive Director |
| Stuart MacDonald |
Events
| Quarter | Results | Share move |
|---|---|---|
| Q4 2025 | Aug 27, 2025 | −9.3% |
| Q2 2025 | Feb 18, 2025 | −16.1% |
| Q2 2023 | Feb 15, 2023 · Before open | +12.3% |
| Q4 2022 | Aug 23, 2022 · After close | +7.3% |
| Q2 2022 | Feb 14, 2022 · After close | −7.3% |
| Q4 2021 | Aug 27, 2021 | 0.0% |
| Q2 2021 | Feb 22, 2021 | −4.0% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| FY2026 Earnings Presentation | Earnings | 19 slides | Aug 28, 2026 |
| H1 2026 Earnings Presentation | Earnings | 17 slides | Feb 19, 2026 |
| FY2025 Earnings Presentation | Earnings | 22 slides | Aug 28, 2025 |
| H1 2025 Earnings Presentation | Earnings | 25 slides | Feb 19, 2025 |
| Shareholder Meeting (November 2024) | Shareholder meeting | 44 slides | Nov 28, 2024 |
| FY2024 Earnings Presentation | Earnings | 30 slides | Aug 27, 2024 |
| FY2024 Earnings Presentation | Earnings | 25 slides | Aug 6, 2024 |
| Investor Presentation (February 2024) | Investor deck | 32 slides | Feb 14, 2024 |
| Shareholder Meeting (November 2023) | Shareholder meeting | 28 slides | Nov 21, 2023 |
| Investor Presentation (August 2023) | Investor deck | 29 slides | Aug 24, 2023 |
All 23 decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Q3 FY23 Earnings Presentation | Earnings | 17 slides | Apr 27, 2023 |
| Investor Presentation (February 2023) | Investor deck | 32 slides | Feb 15, 2023 |
| Shareholder Meeting (November 2022) | Shareholder meeting | 23 slides | Nov 24, 2022 |
| Investor Presentation (August 2022) | Investor deck | 28 slides | Aug 24, 2022 |
| Corporate Update (May 2022) | Corporate update | 11 slides | May 17, 2022 |
| H1 FY2022 Earnings Presentation | Earnings | 26 slides | March 2022 |
| H1 FY2022 Earnings Presentation | Earnings | 30 slides | Feb 15, 2022 |
| Shareholder Meeting (October 2021) | Shareholder meeting | 22 slides | Oct 28, 2021 |
| Merger or Acquisition (August 2021) | Merger or acquisition | 25 slides | Aug 30, 2021 |
| H1 FY2021 Earnings Presentation | Earnings | 30 slides | Aug 27, 2021 |
| Investor Presentation (August 2021) | Investor deck | 35 slides | Aug 27, 2021 |
| Pacific Knowledge Systems — Investor Presentation (August 2020) | Investor deck | 29 slides | Aug 28, 2020 |
| IPO Roadshow (June 2019) | IPO roadshow | 40 slides | Jun 14, 2019 |
Financials
Annual, in AUD
Income statement
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 29.2M | 28.6M | 27.6M | 22.8M | 16.5M | 8.39M | 4.12M | 294.4K | 3.87M | 3.05M |
| Cost of revenue | 29.9M | 23.7M | 22.7M | 20.6M | 16.7M | 5.62M | 1.47M | 281.4K | 50.0K | 32.0K |
| Gross profit | -738.0K | 28.6M | 4.89M | 2.14M | -202.0K | 2.77M | 2.65M | 13.0K | 3.82M | 3.02M |
| Research and development | 2.96M | 2.31M | 1.68M | 796.0K | 507.0K | 139.6K | 11.0K | |||
| Selling, general and administrative | 23.8M | 21.8M | 1.25M | 18.1M | 13.8M | 5.00M | 1.56M | 475.9K | 1.39M | 1.83M |
| Operating income | -4.99M | -6.23M | -609.0K | -7.01M | -8.65M | -1.03M | 188.0K | -540.8K | 2.04M | 837.0K |
| Depreciation and amortization | 5.13M | 5.52M | 5.44M | 4.89M | 3.62M | 1.50M | 509.1K | 31.0K | 50.0K | 32.0K |
| EBITDA | 139.0K | -713.0K | 4.83M | -2.12M | -5.03M | 465.3K | 697.1K | -509.8K | 2.09M | 869.0K |
| Interest expense | 239.0K | 169.0K | 57.0K | 56.0K | 25.0K | 14.3K | 5.75K | 2 | 0 | 0 |
| Income before tax | -18.2M | -6.35M | -5.83M | -6.19M | -5.97M | -491.8K | 331.1K | -842.7K | 2.18M | 1.36M |
| Income tax | 86.0K | -191.0K | -724.0K | 719.0K | -1.52M | -108.1K | -51.8K | 89.7K | 609.0K | -1.19M |
| Net income | -18.3M | -6.16M | -5.11M | -6.91M | -4.45M | -383.6K | 382.9K | -932.4K | 1.57M | 2.54M |
| Earnings per share, basic | -0.06 | -0.02 | -0.02 | -0.03 | -0.02 | -0.00 | 0.00 | -0.01 | 0.01 | 0.02 |
Balance sheet
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 2.51M | 4.78M | 5.04M | 8.81M | 6.35M | 14.1M | 4.20M | 4.14M | 285.0K | 1.25M |
| Short-term investments | 1.17M | 1.26M | 732.0K | 648.0K | 353.0K | 231.9K | 109.8K | 15.0K | 15.0K | |
| Receivables | 5.48M | 3.54M | 6.48M | 5.64M | 6.90M | 1.78M | 990.1K | 1.19M | 470.0K | 590.0K |
| Inventory | 1.26M | -333.0K | 1 | 352.7K | 331.9K | -293.2K | ||||
| Current assets | 7.99M | 9.61M | 11.5M | 14.4M | 13.3M | 17.4M | 5.55M | 5.33M | 755.0K | 1.84M |
| Property, plant and equipment | 1.16M | 1.38M | 520.0K | 965.0K | 1.44M | 124.5K | 68.4K | 91.0K | 113.0K | |
| Goodwill | 21.4M | 30.9M | 30.9M | 30.9M | 30.9M | 18.6M | 22.1M | 12.7M | 12.7M | |
| Total assets | 37.4M | 54.3M | 59.7M | 62.5M | 63.9M | 47.1M | 32.2M | 21.4M | 6.97M | 5.42M |
| Accounts payable | 596.0K | 1.17M | 763.0K | 1.51M | 736.0K | 238.9K | 425.3K | 119.6K | 128.0K | 182.0K |
| Current liabilities | 12.8M | 7.81M | 9.00M | 12.2M | 8.92M | 3.76M | 2.79M | 975.1K | 1.42M | 1.45M |
| Long-term debt | 2.31M | 537.0K | 537.0K | 537.0K | ||||||
| Total debt | 4.04M | 3.26M | 1.66M | 755.0K | 1.12M | 799.4K | 44.3K | |||
| Total liabilities | 14.0M | 12.4M | 12.5M | 15.3M | 15.3M | 4.96M | 3.01M | 1.19M | 1.42M | 1.45M |
| Shareholders' equity | 23.4M | 41.9M | 47.1M | 47.2M | 48.6M | 42.1M | 29.2M | 20.2M | 5.55M | 3.98M |
| Shares outstanding | 290.2M | 289.6M | 281.4M | 246.4M | 240.0M | 198.5M | 145.9M | 117.5M | 113.9M | 113.9M |
Cash flow
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 931.0K | 609.0K | -492.0K | 768.0K | -2.32M | 240.7K | 1.05M | -1.02M | 1.99M | 922.0K |
| Capital spending | -151.0K | -2.45M | -4.02M | -2.65M | -2.51M | -2.88M | -1.07M | -119.3K | -386.0K | -75.0K |
| Free cash flow | 780.0K | -1.84M | -4.51M | -1.88M | -4.83M | -2.64M | -26.1K | -1.14M | 1.61M | 847.0K |
| Cash from investing | -3.89M | -2.45M | -4.02M | -2.65M | -5.16M | -2.98M | -849.5K | -15.6M | -2.96M | -1.35M |
| Cash from financing | 694.0K | 1.58M | 749.0K | 4.34M | -286.0K | 12.6M | -128.5K | 20.7M | 3.00K | -1.20M |
| Dividends paid | -109.0K | |||||||||
| Share buybacks | 995.0K | 4.70M | 240.0K | -540.4K | 0 | 21.7M | 3.00K | 0 | ||
| Change in cash | -2.27M | -262.0K | -3.77M | 2.46M | -7.77M | 9.91M | 68.6K | 3.85M | -965.0K | 1.25M |
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| Annual Report to shareholders | Oct 22, 2026 | Annual report | ASX |
| Notice of Annual General Meeting/Proxy Form | Oct 22, 2026 | Meeting notice | ASX |
| Notification of cessation of securities - BMT | Oct 20, 2026 | Financing | ASX |
| Notification of cessation of securities - BMT | Oct 6, 2026 | Financing | ASX |
| Change of Director's Interest Notice - M Hill | Sep 3, 2026 | Ownership change notice | ASX |
| Change of Director's Interest Notice - M Bowles | Aug 31, 2026 | Ownership change notice | ASX |
| Cleansing Notice | Aug 27, 2026 | Financing | ASX |
| Application for quotation of securities - BMT | Aug 27, 2026 | Financing | ASX |
| FY26 Annual Results Investor Presentation | Aug 27, 2026 | Other filings | ASX |
| Appendix 4G and Corporate Governance Statement | Aug 27, 2026 | Other filings | ASX |
All 107 filings
Cap table
Built by 6ix from Beamtree Holdings Ltd’s releases
- Common shares
- 295,342,591
- Fully diluted
- 295,342,591
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 295,342,591 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 295,342,591 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Andy Hardy | Non-Executive Director · Since at least Nov 4, 2026 |
| Anna Winyard | General Manager, UK and Europe · Since at least Nov 5, 2026 |
| Cheryl McCullagh | General Manager, ANZ Chief Clinical and Innovation Officer · Since at least Nov 5, 2026 |
| David Crockett | Chief Growth Officer · Since at least Nov 5, 2026 |
| Emma Gray | Director · Since at least Nov 5, 2026 |
| Evan Simmons | Head of Diagnostics Products · Since at least Nov 4, 2026 |
| Gareth Pye | Chief Executive Officer · Since Jun 15, 2026 |
| Hani Obeid | General Manager, Saudi Arabia and Middle East · Since at least Nov 5, 2026 |
| Julia Cooper | General Manager of Health Roundtable · Since at least Nov 5, 2026 |
| Kateena Mills | Head of People & Culture · Since at least Nov 5, 2026 |
All 18 people
| Person | Seat |
|---|---|
| Larissa Mason | Head of Clinical Decision Support · Since at least Nov 4, 2026 |
| Marek Stepniak | Head of International · Since at least Nov 5, 2026 |
| Martin Bowles AO PSM | Director · Since at least Nov 5, 2026 |
| Mike Hill | Non-Executive Director · Since at least Nov 4, 2026 |
| Neil Thompson | Chief Financial Officer · Since at least Nov 5, 2026 |
| Stephen Badham | Head of Coding Products · Since at least Nov 4, 2026 |
| Stephen Morgan | Chief Technology Officer · Since at least Nov 5, 2026 |
| Stuart MacDonald | Director · Since at least Nov 5, 2026 |
Log in to ask 6ix AI your own questions about Beamtree Holdings Ltd.